TOPIC:

MS multiple sclerosis, wheel chair bound

I do not find any references to MS in Jim's book; however protocol 2000 the cancer protocol is recommended for "Incurable disease bad problems" p. 30. In Jim's lecture transcripts there are a couple references to MS. Jim is asked what to do about an MS case that is chair bound and he says, "Use protocol 2000 until well."

In another place there is a discussion about DMSO and bad MS:

(Jim quizzes students) What would you do for lumbago (low back pain)?
(Student) Three drops hourly plus mms/dmso mixed together and applied right away?
(Jim) Yes. For pain you can use dmso alone, but the two together is even more effective.
Q: How does it work on pain?
A: It is a solvent, so the action of dmso is that it dissolves things, including blood clots, and of course pain.
Q: Can it dissolve blood clots in the brain?
A: Yes, if taken by mouth, every 15 minutes, diluted with juice, one or two teaspoons each dosage.
Q: Is there a maximum time limit on treating with dmso after someone has had a stroke?
A: Up to six years at least.
Q: Are there dead cells that won’t re-generate in the brain?
A: A lot of times it just slows the cells down but doesn’t kill them.
Q: Would it help to mix dmso with olive oil and apply to the stroke victim’s arm?
A: Yes, try everything and anything.
Q: Should you add mms at some point after the dmso treatments?
A: Yes. Protocol 1000.
....
Q: Can dmso help with bad MS?
A: Yes. You should use ½-1 teaspoon every hour until you see noticeable improvement.
Q: Should you take the dmso and mms protocol at the same time ?
A: Yes, I don’t think it would hurt to take them at the same time.
Q: So activate the mms, add dmso to this?
A: I would make them up separate, but no time in between the dosages is needed. I worry about mixing them together in the same glass, but not about doing the dosages at the same time.

DMSO is a very powerful nerve healer, miraculous even. I remember reading it could heal severed spinal cords when used soon enough and stop brain damage from strokes. In the discussion above Jim is talking about taking DMSO .5-1 teaspoon by mouth every hour along with the protocol 2000 MMS doses; they can be taken at the same time but not put into the same glass together. He also mentions that stroke victims may see improvement taking DMSO by mouth even up to 6 yrs after the stroke.

I think the DMSO and MMS together are a great strategy for MS, and also for ALS (Lou Gerhigs) or any other nerve conditions or brain damage conditions.

Michael

A note about mixing activated MMS and DMSO in the same container:

When Jim came out with the revised Protocol 3000, I was surprised that they were proposing mixing the DMSO in the same solution. But it came to me that I could do a simple experiment to see if the DMSO was neutralizing the chlorine dioxide - I mixed up a 1 oz. batch of MMS at the topical solution dilution of 10 drops per 1 oz. of water and put it in a sealed jar with 1/2 tsp. DMSO. Long story short, the solution had not lost any of its ClO2 yellowness after 2 weeks. Don't think there's a problem with mixing the substances.

Bruce posted this on another ALS question (Thanks Bruce!):

I don't know if there is direct evidence of MMS effectiveness against ALS. When I was taking my Minister of Health training in the Dominican Republic, Jim Humble was of the opinion that Protocol 2000, with the added use of MMS2/calcium hypochlorite, would likely be effective.

This is a quote off of curezone.org :

"I have a friend with ALS. I asked someone I know who is a medical professional to comment regarding the use of MMS in such a case. This is his response:"

'"To use the biggest word, IF ALS is caused by a virus, MMS may be the best treatment available. The myelin sheath is rich in lipids which would tend to protect elements in the nerve bundle. MMS would stand a better chance of penetrating than other medicaments because of the small size of the molecule. Even so, it may also be very helpful in preventing spread or progression of the disease if transmission to other areas involves passage through the blood. MMS is most effective against micro-organisms in the blood - e.g. malaria, AIDS, but while possibly effective against conditions such as Lymes disease it requires higher dosages for longer periods of time to penetrate to the organisms (borrelia)."'

BTW, I've also read quite a bit about people having success with ALS with (whole plant/oral) Hemp Medicine (see the Rick Simpson videos like Run From The Cure).

source: genesis2forum.org/index.php?option=com_kunena&func=view&catid=2&id=3650&Itemid=66#3662

More info on hemp oil for ALS; this is medical hemp oil (Hash oil) that his high in THC, not the 'hemp oil' from hemp seeds sold in the grocery stores. It looks they have a good medical info database on this norml.org site www.norml.org/index.cfm?Group_ID=7002.


norml.org/index.cfm?Group_ID=7004
Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a fatal neurodegenerative disorder that is characterized by the selective loss of motor neurons in the spinal cord, brain stem, and motor cortex. An estimated 30,000 Americans are living with ALS, which often arises spontaneously and afflicts otherwise healthy adults. More than half of ALS patients die within 2.5 years following the onset of symptoms.

A review of the scientific literature reveals an absence of clinical trials investigating the use of cannabinoids for ALS treatment. However, recent preclinical findings indicate that cannabinoids can delay ALS progression, lending support to anecdotal reports by patients that cannabinoids may be efficacious in moderating the disease’s development and in alleviating certain ALS-related symptoms such as pain, appetite loss, depression and drooling.[1]

Writing in the March 2004 issue of the journal Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders, investigators at the California Pacific Medical Center in San Francisco reported that the administration of THC both before and after the onset of ALS symptoms staved disease progression and prolonged survival in animals compared to untreated controls.[2]

Additional trials in animal models of ALS have shown that the administration of other naturally occurring and synthetic cannabinoids can also moderate ALS progression but not necessarily impact survival.[3-4] One recent study demonstrated that blocking the CB1 cannabinoid receptor did extend life span in an ALS mouse model, suggesting that cannabinoids’ beneficial effects on ALS may be mediated by non-CB1 receptor mechanisms.[5]

As a result, experts are calling for clinical trials to assess cannabinoids for the treatment of ALS. Writing in the American Journal of Hospice & Palliative Medicine in 2010, a team of investigators reported, "Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease." They concluded, "There is an overwhelming amount of preclinical and clinical evidence to warrant initiating a multicenter randomized, double-blind, placebo-controlled trial of cannabis as a disease-modifying compound in ALS."[6]

REFERENCES

[1] Amtmann et al. 2004. Survey of cannabis use in patients with amyotrophic lateral sclerosis. The American Journal of Hospice and Palliative Care 21: 95-104.

[2] Raman et al. 2004. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders 5: 33-39.

[3] Weydt et al. 2005. Cannabinol delays symptom onset in SOD1 transgenic mice without affecting survival. Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders 6: 182-184.

[4] Bilsland et al. 2006. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. The FASEB Journal 20: 1003-1005.

[5] Ibid.

[6]Carter et al. 2010. Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. American Journal of Hospice & Palliative Medicine 27: 347-356.